Variant position: 342 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 821 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KEIEVLYIRNVTFEDAGEYT CLAGNSIGISFHSAWLTVL----PA
Mouse KEIEVLYIRNVTFEDAGEYT CLAGNSIGISFHSAWLTVL--
Chicken KEIEVLYIRNVTFEDAGEYT CLAGNSIGISFHTAWLTVL--
Xenopus laevis EEIEVLYVRNVSFEDAGEYT CIAGNSIGISQHSAWLTVH--
Zebrafish KEIEVLYLPNVTFEDAGEYT CLAGNSIGISYHTAWLTVH--
Drosophila DSV-VLTLRNVTFDQEGWYT CLASSGLGRSNSSVYLRVVSP
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
22 – 821 Fibroblast growth factor receptor 2
22 – 377 Extracellular
256 – 358 Ig-like C2-type 3
331 – 331 N-linked (GlcNAc...) asparagine
278 – 342
250 – 361 Missing. In isoform 23.
255 – 821 Missing. In isoform 14.
314 – 429 Missing. In isoform 15.
341 – 353 TCLAGNSIGISFH -> ICKVSNYIGQANQ. In isoform 3, isoform 4, isoform 7, isoform 9, isoform 10, isoform 11, isoform 12, isoform 13, isoform 17, isoform 18, isoform 19 and isoform 22.
361 – 361 P -> PKQQ. In isoform 3, isoform 4, isoform 7, isoform 9, isoform 10, isoform 11, isoform 12, isoform 13, isoform 17, isoform 18, isoform 19 and isoform 22.
338 – 345
Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome.
Cornejo-Roldan L.R.; Roessler E.; Muenke M.;
Hum. Genet. 104:425-431(1999)
Cited for: VARIANTS PS CYS-340 AND GLY-342;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.